Content about Boston Scientific Corporation

03.11.10

Boston Scientific Corporation today announced that the U.S. Food and Drug Administration (FDA) has approved its Express® LD Iliac Premounted Stent System for use in iliac arteries. The Express LD Iliac Stent is the first and only low-profile, premounted, balloon-expandable stent approved by the FDA for use in treating iliac artery disease. The Company said it plans to launch the product immediately in the United States.

11.12.09

Boston Scientific Corporation (NYSE: BSX) announced its schedule of events at the 38th annual Global Congress for Minimally Invasive Gynecology (AAGL), which runs from November 15-19 in Orlando, Florida.